 Omid Jazaeri
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 7 | 2021 | 349 | 0.880 |
Why?
| | Vascular Surgical Procedures | 7 | 2023 | 325 | 0.740 |
Why?
| | Homophobia | 1 | 2021 | 3 | 0.720 |
Why?
| | Sexism | 2 | 2023 | 67 | 0.720 |
Why?
| | Aorta, Thoracic | 3 | 2018 | 276 | 0.670 |
Why?
| | Cultural Diversity | 1 | 2021 | 79 | 0.660 |
Why?
| | Renal Insufficiency | 1 | 2022 | 169 | 0.620 |
Why?
| | Terminology as Topic | 1 | 2021 | 243 | 0.610 |
Why?
| | Racism | 1 | 2021 | 137 | 0.600 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 741 | 0.550 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2018 | 136 | 0.500 |
Why?
| | Hemodynamics | 2 | 2018 | 1093 | 0.490 |
Why?
| | Blood Vessel Prosthesis Implantation | 5 | 2020 | 222 | 0.490 |
Why?
| | Kidney | 1 | 2022 | 1466 | 0.420 |
Why?
| | Iliac Artery | 3 | 2020 | 57 | 0.410 |
Why?
| | Surgeons | 3 | 2023 | 327 | 0.410 |
Why?
| | Anesthetics | 1 | 2011 | 98 | 0.330 |
Why?
| | Blood Vessel Prosthesis | 3 | 2020 | 138 | 0.300 |
Why?
| | Aortic Aneurysm, Abdominal | 2 | 2020 | 160 | 0.280 |
Why?
| | Lower Extremity | 3 | 2015 | 434 | 0.250 |
Why?
| | Education, Medical, Graduate | 2 | 2021 | 496 | 0.240 |
Why?
| | Stents | 3 | 2020 | 526 | 0.240 |
Why?
| | Intermittent Claudication | 3 | 2016 | 122 | 0.230 |
Why?
| | Aortic Diseases | 2 | 2017 | 119 | 0.230 |
Why?
| | Vascular System Injuries | 2 | 2018 | 76 | 0.230 |
Why?
| | Peripheral Arterial Disease | 3 | 2015 | 486 | 0.210 |
Why?
| | Ischemia | 3 | 2016 | 414 | 0.200 |
Why?
| | Specialties, Surgical | 1 | 2023 | 77 | 0.190 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 1157 | 0.190 |
Why?
| | Perfusion Imaging | 2 | 2018 | 62 | 0.170 |
Why?
| | Vascular Diseases | 1 | 2023 | 240 | 0.170 |
Why?
| | Receptors, Estrogen | 2 | 2000 | 409 | 0.160 |
Why?
| | Blood Flow Velocity | 2 | 2018 | 411 | 0.160 |
Why?
| | Alloys | 1 | 2020 | 37 | 0.160 |
Why?
| | Magnetic Resonance Angiography | 2 | 2018 | 243 | 0.150 |
Why?
| | Regional Blood Flow | 2 | 2018 | 496 | 0.150 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 19 | 0.150 |
Why?
| | Femoral Vein | 1 | 2018 | 35 | 0.150 |
Why?
| | Aortography | 1 | 2018 | 54 | 0.140 |
Why?
| | Iliac Vein | 1 | 2018 | 14 | 0.140 |
Why?
| | Washington | 1 | 2018 | 157 | 0.140 |
Why?
| | Sexual and Gender Minorities | 1 | 2021 | 229 | 0.130 |
Why?
| | Societies, Medical | 1 | 2021 | 839 | 0.130 |
Why?
| | Computed Tomography Angiography | 1 | 2018 | 131 | 0.130 |
Why?
| | Endometrial Neoplasms | 1 | 1999 | 196 | 0.130 |
Why?
| | Venous Thrombosis | 1 | 2018 | 190 | 0.130 |
Why?
| | Vascular Grafting | 1 | 2016 | 15 | 0.120 |
Why?
| | United States | 7 | 2023 | 14938 | 0.120 |
Why?
| | Male | 17 | 2023 | 68260 | 0.120 |
Why?
| | Sex Factors | 1 | 2021 | 2044 | 0.120 |
Why?
| | Humans | 21 | 2023 | 138651 | 0.110 |
Why?
| | Risk Assessment | 4 | 2020 | 3433 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2019 | 427 | 0.110 |
Why?
| | Female | 16 | 2023 | 73763 | 0.110 |
Why?
| | Aged | 10 | 2020 | 24024 | 0.110 |
Why?
| | Multiple Trauma | 1 | 2014 | 104 | 0.100 |
Why?
| | Thoracotomy | 1 | 2014 | 80 | 0.100 |
Why?
| | Postoperative Complications | 4 | 2020 | 2722 | 0.100 |
Why?
| | Vascular Stiffness | 1 | 2017 | 443 | 0.100 |
Why?
| | Femoral Artery | 1 | 2014 | 182 | 0.100 |
Why?
| | Treatment Outcome | 9 | 2020 | 10923 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1374 | 0.100 |
Why?
| | Middle Aged | 10 | 2023 | 33604 | 0.100 |
Why?
| | RNA, Messenger | 2 | 2000 | 2815 | 0.090 |
Why?
| | Retrospective Studies | 7 | 2019 | 15909 | 0.090 |
Why?
| | Seasons | 1 | 2014 | 538 | 0.090 |
Why?
| | Aortic Rupture | 1 | 2011 | 27 | 0.090 |
Why?
| | Prevalence | 1 | 2018 | 2727 | 0.090 |
Why?
| | Internship and Residency | 1 | 2021 | 1187 | 0.090 |
Why?
| | Aged, 80 and over | 3 | 2020 | 7677 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 1045 | 0.080 |
Why?
| | Incidence | 4 | 2018 | 2747 | 0.070 |
Why?
| | Acute Disease | 1 | 2011 | 994 | 0.070 |
Why?
| | Risk Factors | 6 | 2020 | 10252 | 0.070 |
Why?
| | Athletic Injuries | 1 | 2014 | 517 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1059 | 0.070 |
Why?
| | Adult | 7 | 2023 | 38201 | 0.060 |
Why?
| | Young Adult | 3 | 2018 | 13305 | 0.060 |
Why?
| | Stroke | 1 | 2015 | 1136 | 0.060 |
Why?
| | Registries | 4 | 2020 | 2073 | 0.060 |
Why?
| | Time Factors | 4 | 2020 | 6851 | 0.060 |
Why?
| | Factor VII | 1 | 2005 | 25 | 0.060 |
Why?
| | Factor VIIa | 1 | 2005 | 42 | 0.060 |
Why?
| | Vascular Patency | 2 | 2016 | 109 | 0.060 |
Why?
| | Liver Cirrhosis | 1 | 2006 | 278 | 0.050 |
Why?
| | Reoperation | 2 | 2018 | 579 | 0.050 |
Why?
| | Curriculum | 2 | 2021 | 1009 | 0.050 |
Why?
| | Trauma Severity Indices | 2 | 2018 | 109 | 0.050 |
Why?
| | Patient Selection | 2 | 2019 | 676 | 0.050 |
Why?
| | Wounds, Nonpenetrating | 1 | 2005 | 304 | 0.050 |
Why?
| | Perception | 1 | 2023 | 369 | 0.040 |
Why?
| | Hemorrhage | 1 | 2005 | 747 | 0.040 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2020 | 61 | 0.040 |
Why?
| | Educational Status | 1 | 2021 | 462 | 0.040 |
Why?
| | DNA, Neoplasm | 1 | 1999 | 157 | 0.040 |
Why?
| | Wounds and Injuries | 1 | 2006 | 833 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2018 | 39 | 0.040 |
Why?
| | Educational Measurement | 1 | 2021 | 299 | 0.040 |
Why?
| | Canada | 1 | 2020 | 407 | 0.040 |
Why?
| | Injury Severity Score | 2 | 2014 | 544 | 0.040 |
Why?
| | Exons | 1 | 1999 | 353 | 0.030 |
Why?
| | Ligation | 1 | 2018 | 93 | 0.030 |
Why?
| | Cryopreservation | 1 | 2018 | 104 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2020 | 333 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 5803 | 0.030 |
Why?
| | Treatment Failure | 1 | 2018 | 351 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 2000 | 245 | 0.030 |
Why?
| | Patient-Specific Modeling | 1 | 2017 | 42 | 0.030 |
Why?
| | Program Evaluation | 1 | 2021 | 916 | 0.030 |
Why?
| | Career Choice | 1 | 2019 | 229 | 0.030 |
Why?
| | Survival Rate | 2 | 2015 | 1935 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 2018 | 122 | 0.030 |
Why?
| | Prospective Studies | 2 | 2020 | 7554 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2017 | 197 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2017 | 197 | 0.030 |
Why?
| | Ankle Brachial Index | 1 | 2016 | 37 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 334 | 0.030 |
Why?
| | Arterial Occlusive Diseases | 1 | 2016 | 83 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2017 | 487 | 0.030 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2017 | 272 | 0.030 |
Why?
| | Extremities | 1 | 2016 | 139 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2017 | 3523 | 0.030 |
Why?
| | Angiography | 1 | 2015 | 207 | 0.030 |
Why?
| | California | 1 | 2015 | 436 | 0.030 |
Why?
| | Limb Salvage | 1 | 2014 | 65 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2014 | 200 | 0.030 |
Why?
| | Clinical Competence | 1 | 2021 | 1149 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2018 | 980 | 0.030 |
Why?
| | Operative Time | 1 | 2014 | 149 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2030 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 704 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1415 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 896 | 0.020 |
Why?
| | Blood Transfusion | 2 | 2006 | 377 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2015 | 282 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 313 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1229 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3307 | 0.020 |
Why?
| | Comorbidity | 1 | 2015 | 1656 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1238 | 0.020 |
Why?
| | Critical Illness | 1 | 2014 | 831 | 0.020 |
Why?
| | Adolescent | 2 | 2018 | 21564 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2015 | 5112 | 0.010 |
Why?
| | International Normalized Ratio | 1 | 2005 | 47 | 0.010 |
Why?
| | Colorado | 1 | 2015 | 4555 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2005 | 520 | 0.010 |
Why?
| | Quality of Life | 1 | 2015 | 2954 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1352 | 0.010 |
Why?
| | beta 2-Microglobulin | 1 | 2000 | 50 | 0.010 |
Why?
| | Estrogen Receptor beta | 1 | 2000 | 41 | 0.010 |
Why?
| | Endometrium | 1 | 2000 | 60 | 0.010 |
Why?
| | Estrogen Receptor alpha | 1 | 2000 | 143 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 984 | 0.010 |
Why?
| | Colon | 1 | 2000 | 284 | 0.010 |
Why?
|
|
Jazaeri's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|